EUVIMEDEUVIMED entdecken
Open Access

Single-nucleus RNA sequencing demonstrates an autosomal dominant Alzheimer’s disease profile and possible mechanisms of disease protection

Maria Camila Almeida, Sarah J Eger, Caroline He, Morgane Audouard, Arina Nikitina, Stella M K Glasauer, Dasol Han, Barbara Mejía-Cupajita, Juliana Acosta-Uribe, Nelson David Villalba-Moreno, Jessica Lisa Littau, Megan Elcheikhali und 6 weitere

Neuron · 2024-06 · 112 (11) · 1778-1794.e7

DOI: 10.1016/j.neuron.2024.02.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuron, 2024-06. Verfasst von Maria Camila Almeida und 17 weiteren Autor:innen. Beteiligte Einrichtung: Neuroscience Research Institute and Department of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, Santa Barba…. Hauptthemen laut MEDLINE: Alzheimer Disease, Presenilin-1. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIH HHS, Fundação de Amparo à Pesquisa do Estado de São Paulo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Highly penetrant autosomal dominant Alzheimer's disease (ADAD) comprises a distinct disease entity as compared to the far more prevalent form of AD in which common variants collectively contribute to risk. The downstream pathways that distinguish these AD forms in specific cell types have not been deeply explored. We compared single-nucleus transcriptomes among a set of 27 cases divided among PSEN1-E280A ADAD carriers, sporadic AD, and controls. Autophagy genes and chaperones clearly defined the PSEN1-E280A cases compared to sporadic AD. Spatial transcriptomics validated the activation of chaperone-mediated autophagy genes in PSEN1-E280A. The PSEN1-E280A case in which much of the brain was spared neurofibrillary pathology and harbored a homozygous APOE3-Christchurch variant revealed possible explanations for protection from AD pathology including overexpression of LRP1 in astrocytes, increased expression of FKBP1B, and decreased PSEN1 expression in neurons. The unique cellular responses in ADAD and sporadic AD require consideration when designing clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseasePresenilin-1HumansMaleFemaleLow Density Lipoprotein Receptor-Related Protein-1Sequence Analysis, RNAAutophagyTranscriptomeAgedNeuronsMiddle AgedAstrocytesBrainTacrolimus Binding ProteinsAged, 80 and overSingle-Cell Analysis

Stichwörter der Autor:innen

APOE3 ChristchurchPSEN1-E280Aautophagychaperonessingle-nucleus sequencingspatial transcriptomicssporadic Alzheimer's diseasetranscriptomics

Substanzen

Presenilin-1PSEN1 protein, humanLow Density Lipoprotein Receptor-Related Protein-1LRP1 protein, humanTacrolimus Binding Proteins

Autor:innen und Institutionen

  • Neuroscience Research Institute and Department of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, Santa Barbara, CA 93106, USA; Center for Natural and Humans Sciences, Federal Uni…
  • Neuroscience Research Institute and Department of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, Santa Barbara, CA 93106, USA.
  • Neuroscience Research Institute and Department of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, Santa Barbara, CA 93106, USA; Grupo de Neurociencias de Antioquia, School of Medi…
  • Molecular Neuropathology of Alzheimer's Disease, Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
  • Department of Statistics and Applied Probability, University of California, Santa Barbara, Santa Barbara, CA 93106, USA.
  • Grupo de Neurociencias de Antioquia, School of Medicine, Universidad de Antioquia, Medellín 050010, Colombia.

Förderung

  • NIA NIH HHS
  • NIH HHS
  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • National Institutes of Health
  • Biogen
  • Alzheimer's Association

Zitieren

APA

Almeida, M. C., Eger, S. J., He, C., Audouard, M., Nikitina, A., Glasauer, S. M. K., Han, D., Mejía-Cupajita, B., Acosta-Uribe, J., Villalba-Moreno, N. D., Littau, J. L., Elcheikhali, M., Rivera, E. K., Carrettiero, D. C., Villegas-Lanau, C. A., Sepulveda-Falla, D., Lopera, F., & Kosik, K. S. (2024). Single-nucleus RNA sequencing demonstrates an autosomal dominant Alzheimer’s disease profile and possible mechanisms of disease protection. Neuron, 112(11), 1778-1794.e7. https://doi.org/10.1016/j.neuron.2024.02.009

Vancouver

Almeida MC, Eger SJ, He C, Audouard M, Nikitina A, Glasauer SMK, et al. Single-nucleus RNA sequencing demonstrates an autosomal dominant Alzheimer’s disease profile and possible mechanisms of disease protection. Neuron. 2024;112(11):1778-1794.e7. doi:10.1016/j.neuron.2024.02.009

BibTeX
@article{Almeida2024,
  author = {Almeida, Maria Camila and Eger, Sarah J and He, Caroline and Audouard, Morgane and Nikitina, Arina and Glasauer, Stella M K and Han, Dasol and Mejía-Cupajita, Barbara and Acosta-Uribe, Juliana and Villalba-Moreno, Nelson David and Littau, Jessica Lisa and Elcheikhali, Megan and Rivera, Erica Keane and Carrettiero, Daniel Carneiro and Villegas-Lanau, Carlos Andrés and Sepulveda-Falla, Diego and Lopera, Francisco and Kosik, Kenneth S},
  title = {Single-nucleus RNA sequencing demonstrates an autosomal dominant Alzheimer’s disease profile and possible mechanisms of disease protection},
  journal = {Neuron},
  year = {2024},
  volume = {112},
  number = {11},
  pages = {1778--1794.e7},
  doi = {10.1016/j.neuron.2024.02.009}
}
Kostenlos starten →